Risk factors for the development of ocular graft-versus-host disease (GVHD) dry eye syndrome in patients with chronic GVHD

British Journal of Ophthalmology

Volumn 99, Issue 11, 2015, Pages 1514-1518

  Wang, Jay Ching Chieh ^a   Teichman, Joshua C ^b   Mustafa, Majd ^a   O'Donnell, Heather ^a   Broady, Raewyn ^a   Yeung, Sonia N ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASIAN; CAUCASIAN; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRY EYE; EPSTEIN BARR VIRUS INFECTION; ETHNICITY; FEMALE; HIGH RISK PATIENT; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SKIN MANIFESTATION; ADVERSE EFFECTS; ALLOTRANSPLANTATION; BLOOD GROUP ABO SYSTEM; CHRONIC DISEASE; DRY EYE SYNDROMES; ETHNIC GROUP; ETHNOLOGY; FOLLOW UP; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA; MIDDLE AGED; RISK FACTOR;

BLOOD GROUP ABO SYSTEM;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; CHRONIC DISEASE; DRY EYE SYNDROMES; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84945476682     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2014-306438     Document Type: Article

References (23)

1. Hessen M, Akpek EK. Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 2012;12:540-7.
2. Choi SW, Levine JE, Ferrara JL. Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin North Am 2010;30:75-101.
3. Ferrara JL, Levine JE, Reddy P, et al. Graft-versus-host disease. Lancet 2009;373:1550-61.
4. Socie G, Ritz J. Current issues in chronic graft-versus-host disease. Blood 2014;124:374-84.
5. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005;11:945-56.
6. Nassiri N, Eslani M, Panahi N, et al. Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations. J Ophthalmic Vis Res 2013;8:351-8.
7. Riemens A, Te Boome LC, Kalinina Ayuso V, et al. Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study. Acta Ophthalmol 2014;92:82-7.
8. Ogawa Y, Kuwana M. Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 2003;22(7 Suppl):S19-27.
9. Ivanir Y, Shimoni A, Ezra-Nimni O, et al. Prevalence of dry eye syndrome after allogeneic hematopoietic stem cell transplantation. Cornea 2013;32:e97-101.
10. Ogawa Y, Kim SK, Dana R, et al. International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep 2013;3:3419.
11. Westeneng AC, Hettinga Y, Lokhorst H, et al. Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea 2010;29:758-63.
12. Jacobs R, Tran U, Chen H, et al. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant 2012;47:1470-3.
13. Leite SC, de Castro RS, Alves M, et al. Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation. Bone Marrow Transplant 2006;38:223-7.
14. [No authors listed]. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:93-107.
15. Eckrich MJ, Ahn KW, Champlin RE, et al. Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia. Am J Hematol 2014;89:125-9.
16. Fox RI, Luppi M, Pisa P, et al. Potential role of Epstein-Barr virus in Sjogren's syndrome and rheumatoid arthritis. J Rheumatol Suppl 1992;32:18-24.
17. Fox RI, Luppi M, Kang HI, et al. Reactivation of Epstein-Barr virus in Sjogren's syndrome. Springer Semin Immunopathol 1991;13:217-31.
18. Fox RI, Pearson G, Vaughan JH. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome. J Immunol 1986;137:3162-8.
19. Mariette X, Gozlan J, Clerc D, et al. Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjogren's syndrome. Am J Med 1991;90:286-94.
20. Kamoi M, Ogawa Y, Uchino M, et al. Donor-recipient gender difference affects severity of dry eye after hematopoietic stem cell transplantation. Eye (Lond) 2011;25:860-5.
21. Ogawa Y, Okamoto S, Wakui M, et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol 1999;83:1125-30.
22. Tichelli A, Duell T, Weiss M, et al. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects. Bone Marrow Transplant 1996;17:1105-11.
23. Shikari H, Amparo F, Saboo U, et al. Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation. Cornea 2015;34:243-7.